May 18, 2021 – HighLife’s TSMVR System and Clinical Study progress featured at EuroPCR 2021
HighLife SAS, a medtech company focused on the development of a unique Trans-Septal Mitral Valve Replacement (“TSMVR”) system to treat patients suffering from mitral regurgitation, announced today that several presentations will be …
